Smith & Nephew plc (SNN)
USD 24.89
(-2.16%)
USD 24.89
(-2.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.7 Billion USD | 0.16% |
| 2022 | 3.69 Billion USD | -0.08% |
| 2021 | 3.69 Billion USD | 16.33% |
| 2020 | 3.17 Billion USD | -16.5% |
| 2019 | 3.8 Billion USD | 5.57% |
| 2018 | 3.6 Billion USD | 2.53% |
| 2017 | 3.51 Billion USD | 3.53% |
| 2016 | 3.39 Billion USD | -2.69% |
| 2015 | 3.49 Billion USD | 0.03% |
| 2014 | 3.49 Billion USD | 6.79% |
| 2013 | 3.26 Billion USD | 6.55% |
| 2012 | 3.06 Billion USD | -2.01% |
| 2011 | 3.13 Billion USD | 6.79% |
| 2010 | 2.93 Billion USD | 6.89% |
| 2009 | 2.74 Billion USD | 0.66% |
| 2008 | 2.72 Billion USD | 14.69% |
| 2007 | 2.37 Billion USD | 18.16% |
| 2006 | 2.01 Billion USD | 8.59% |
| 2005 | 1.85 Billion USD | 5.62% |
| 2004 | 1.75 Billion USD | 17.7% |
| 2003 | 1.48 Billion USD | 18.54% |
| 2002 | 1.25 Billion USD | 17.92% |
| 2001 | 1.06 Billion USD | -37.15% |
| 2000 | 1.69 Billion USD | -6.45% |
| 1999 | 1.81 Billion USD | 3.61% |
| 1998 | 1.74 Billion USD | 0.92% |
| 1997 | 1.73 Billion USD | -5.37% |
| 1996 | 1.83 Billion USD | 15.46% |
| 1995 | 1.58 Billion USD | 5.16% |
| 1994 | 1.5 Billion USD | 7.46% |
| 1993 | 1.4 Billion USD | 7.88% |
| 1992 | 1.3 Billion USD | -12.19% |
| 1991 | 1.48 Billion USD | 5.25% |
| 1990 | 1.4 Billion USD | 23.53% |
| 1989 | 1.13 Billion USD | 5.76% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.97 Billion USD | 0.0% |
| 2023 Q2 | 1.89 Billion USD | 0.0% |
| 2023 Q4 | 1.9 Billion USD | 0.0% |
| 2023 FY | 3.7 Billion USD | 0.16% |
| 2022 Q2 | 1.82 Billion USD | 0.0% |
| 2022 FY | 3.69 Billion USD | -0.08% |
| 2022 Q4 | 1.93 Billion USD | 0.0% |
| 2021 Q2 | 1.79 Billion USD | 0.0% |
| 2021 FY | 3.69 Billion USD | 16.33% |
| 2021 Q4 | 1.89 Billion USD | 0.0% |
| 2020 Q4 | 1.74 Billion USD | 0.0% |
| 2020 FY | 3.17 Billion USD | -16.5% |
| 2020 Q2 | 1.38 Billion USD | 0.0% |
| 2019 Q2 | 1.83 Billion USD | 0.0% |
| 2019 Q4 | 1.98 Billion USD | 0.0% |
| 2019 FY | 3.8 Billion USD | 5.57% |
| 2018 Q2 | 1.78 Billion USD | 0.0% |
| 2018 FY | 3.6 Billion USD | 2.53% |
| 2018 Q4 | 1.81 Billion USD | 0.0% |
| 2017 FY | 3.51 Billion USD | 3.53% |
| 2017 Q2 | 1.73 Billion USD | 0.0% |
| 2017 Q4 | 1.78 Billion USD | 0.0% |
| 2016 Q4 | 1.7 Billion USD | 0.0% |
| 2016 Q2 | 1.69 Billion USD | 0.0% |
| 2016 FY | 3.39 Billion USD | -2.69% |
| 2015 FY | 3.49 Billion USD | 0.03% |
| 2015 Q4 | 1.78 Billion USD | 0.0% |
| 2015 Q2 | 1.7 Billion USD | 0.0% |
| 2014 Q2 | 1.68 Billion USD | 0.0% |
| 2014 Q4 | 1.8 Billion USD | 0.0% |
| 2014 FY | 3.49 Billion USD | 6.79% |
| 2013 Q2 | 1.61 Billion USD | 0.0% |
| 2013 FY | 3.26 Billion USD | 6.55% |
| 2013 Q4 | 1.65 Billion USD | 0.0% |
| 2012 Q1 | 808 Million USD | -0.25% |
| 2012 Q4 | 787 Million USD | 11.16% |
| 2012 Q2 | 764 Million USD | -5.45% |
| 2012 Q3 | 708 Million USD | -7.33% |
| 2012 FY | 3.06 Billion USD | -2.01% |
| 2011 Q2 | 790 Million USD | 1.41% |
| 2011 FY | 3.13 Billion USD | 6.79% |
| 2011 Q4 | 810 Million USD | 7.86% |
| 2011 Q3 | 751 Million USD | -4.94% |
| 2011 Q1 | 779 Million USD | -0.38% |
| 2010 FY | 2.93 Billion USD | 6.89% |
| 2010 Q4 | 782 Million USD | 12.36% |
| 2010 Q3 | 696 Million USD | -2.52% |
| 2010 Q2 | 714 Million USD | -3.38% |
| 2010 Q1 | 739 Million USD | -3.4% |
| 2009 Q3 | 669 Million USD | -0.89% |
| 2009 Q2 | 675 Million USD | 6.64% |
| 2009 Q1 | 633 Million USD | -9.31% |
| 2009 Q4 | 765 Million USD | 14.35% |
| 2009 FY | 2.74 Billion USD | 0.66% |
| 2008 Q4 | 698 Million USD | 6.4% |
| 2008 Q2 | 715 Million USD | 9.16% |
| 2008 Q3 | 656 Million USD | -8.25% |
| 2008 Q1 | 655 Million USD | -2.82% |
| 2008 FY | 2.72 Billion USD | 14.69% |
| 2007 Q2 | 576 Million USD | 4.54% |
| 2007 Q1 | 551 Million USD | 0.18% |
| 2007 Q3 | 574 Million USD | -0.35% |
| 2007 Q4 | 674 Million USD | 17.42% |
| 2007 FY | 2.37 Billion USD | 18.16% |
| 2006 Q2 | 498 Million USD | 6.41% |
| 2006 FY | 2.01 Billion USD | 8.59% |
| 2006 Q4 | 550 Million USD | 11.34% |
| 2006 Q3 | 494 Million USD | -0.8% |
| 2006 Q1 | 468 Million USD | 259.6% |
| 2005 Q1 | 472 Million USD | -8.9% |
| 2005 Q3 | 443.99 Million USD | -4.38% |
| 2005 Q4 | -293.22 Million USD | -166.04% |
| 2005 Q2 | 464.34 Million USD | -1.62% |
| 2005 FY | 1.85 Billion USD | 5.62% |
| 2004 Q3 | 409.57 Million USD | 0.28% |
| 2004 FY | 1.75 Billion USD | 17.7% |
| 2004 Q4 | 518.13 Million USD | 26.5% |
| 2004 Q1 | 403.98 Million USD | -11.91% |
| 2004 Q2 | 408.43 Million USD | 1.1% |
| 2003 Q3 | 513.9 Million USD | -0.51% |
| 2003 Q1 | 307.31 Million USD | -0.61% |
| 2003 Q4 | 458.61 Million USD | -10.76% |
| 2003 FY | 1.48 Billion USD | 18.54% |
| 2003 Q2 | 516.53 Million USD | 68.08% |
| 2002 FY | 1.25 Billion USD | 17.92% |
| 2002 Q2 | 401.31 Million USD | -11.65% |
| 2002 Q3 | 503.34 Million USD | 25.42% |
| 2002 Q4 | 309.21 Million USD | -38.57% |
| 2002 Q1 | 454.24 Million USD | 36.02% |
| 2001 Q4 | 333.94 Million USD | -10.42% |
| 2001 Q1 | 388.22 Million USD | -40.19% |
| 2001 FY | 1.06 Billion USD | -37.15% |
| 2001 Q3 | 372.77 Million USD | -3.9% |
| 2001 Q2 | 387.89 Million USD | -0.09% |
| 2000 Q2 | 416.31 Million USD | -11.76% |
| 2000 FY | 1.69 Billion USD | -6.45% |
| 2000 Q3 | 304.59 Million USD | -26.84% |
| 2000 Q1 | 471.8 Million USD | 3.76% |
| 2000 Q4 | 649.07 Million USD | 113.1% |
| 1999 Q2 | 72.8 Million USD | -84.31% |
| 1999 Q1 | 464.1 Million USD | 0.0% |
| 1999 FY | 1.81 Billion USD | 3.61% |
| 1999 Q4 | 454.72 Million USD | 1.56% |
| 1999 Q3 | 447.73 Million USD | 515.03% |
| 1998 FY | 1.74 Billion USD | 0.92% |
| 1997 FY | 1.73 Billion USD | -5.37% |
| 1996 FY | 1.83 Billion USD | 15.46% |
| 1995 FY | 1.58 Billion USD | 5.16% |
| 1994 FY | 1.5 Billion USD | 7.46% |
| 1993 FY | 1.4 Billion USD | 7.88% |
| 1992 FY | 1.3 Billion USD | -12.19% |
| 1991 FY | 1.48 Billion USD | 5.25% |
| 1990 FY | 1.4 Billion USD | 23.53% |
| 1989 FY | 1.13 Billion USD | 5.76% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 83.279% |
| Allurion Technologies Inc. | 41.49 Million USD | -8818.717% |
| Artivion, Inc. | 229.17 Million USD | -1514.916% |
| Avanos Medical, Inc. | 379.7 Million USD | -874.717% |
| Butterfly Network, Inc. | 16.85 Million USD | -21856.573% |
| Butterfly Network, Inc. | 16.85 Million USD | -21856.573% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | -158.568% |
| Boston Scientific Corporation | 9.89 Billion USD | 62.597% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -226399.388% |
| CONMED Corporation | 643.06 Million USD | -475.523% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | 19.978% |
| Paragon 28, Inc. | 172.79 Million USD | -2041.894% |
| Glaukos Corporation | 239.13 Million USD | -1447.655% |
| Globus Medical, Inc. | 1.02 Billion USD | -262.736% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -600.651% |
| Integer Holdings Corporation | 418.28 Million USD | -784.795% |
| Medtronic plc | 19.45 Billion USD | 80.975% |
| Nevro Corp. | 290.06 Million USD | -1175.943% |
| Owlet, Inc. | 22.58 Million USD | -16285.532% |
| Penumbra, Inc. | 682.64 Million USD | -442.157% |
| Vicarious Surgical Inc. | -1.85 Million USD | 199722.438% |
| Sonendo, Inc. | 10.72 Million USD | -34417.814% |
| STERIS plc | 2.23 Billion USD | -65.667% |
| Stryker Corporation | 13.05 Billion USD | 71.657% |
| Vapotherm, Inc. | 28.28 Million USD | -12985.599% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 30.307% |